St John’s Wort Complementary Therapy for ADHD
A randomized, double-blind, placebo-controlled trial of hypericum perforatum (St John’s Wort) in the treatment of attention-deficit/hyperactivity disorder (ADHD) was conducted in 54 children aged 6 to 17 years at Bastyr University, Kenmore, WA.
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
2008-06-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/905 |